Dr Klingmann has over 30 years of experience in different senior medical, operational and managerial functions in pharmaceutical industry, CROs and clinical trial sites with focus on clinical trial design and management, ethical and regulatory aspects.
She is Chairman of the Board of the European Forum for Good Clinical Practice (EFGCP) and currently co-chairing the EU-X-CT Initiative on facilitating cross-border access to clinical trials in Europe. Her broad professional background as physician with experience in patient care, clinical development, site management, regulatory affairs, clinical research ethics, patient involvement and teaching enables her to bridge the gaps between the interests and skills of all different stakeholders in medicines development with the aim to develop new patient-relevant treatments more efficiently.
